香港醫思醫療集團(02138.HK)截至3月底有69名全職專屬註冊醫務人員提供痛症管理業務
格隆匯4月14日丨香港醫思醫療集團(02138.HK)公吿,有見於香港對痛症治療的殷切需求,集團自2016年開始通過紐約醫療集團品牌開展痛症管理和保健的醫療服務業務。截至2021年3月31日,集團在香港設有35個相關服務中心,其中包括3個旗艦服務中心。這些服務中心的策略性布點遍佈香港島、九龍和新界的甲級商業大廈和住宅區,服務總面積約為70,000平方英尺。
集團的痛症管理業務涵蓋5個主要的醫療學科,包括脊醫、骨科、神經外科、物理治療和中醫。截至2021年3月31日,集團僱有69名全職專屬註冊醫務人員提供痛症管理業務。
為發展痛症管理業務,集團持續投資資訊科技平台及先進醫療設備,並專注於發展品牌和提高服務質素。集團的痛症管理業務已在過去數年在香港普及,並致力於帶領行業發展及革新。集團將通過有機增長以及潛在併購,探索痛症管理業務於中國內地和亞洲地區的擴展機會。
監於香港在痛症管理和保健領域對醫學人才的需求不斷增長,集團將利用其領先的專業知識,帶領亞洲地區痛症管理的學術研究。此外,集團將夥同國際醫學院一起推進脊骨神經科學術發展及為脊醫提供在職培訓。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.